Literature DB >> 6476363

A semiautomated microculture method for investigating growth inhibitory effects of cytotoxic compounds on exponentially growing carcinoma cells.

G J Finlay, B C Baguley, W R Wilson.   

Abstract

A method is described by which the growth inhibitory effects of cytotoxic compounds on exponentially growing adherent cell lines can be quantitated. Cultures are established in microtiter plates and the cytotoxic compounds to be tested are added after 2 days. Dilution series are constructed within the microcultures using 8-channel micropipets designed for use with microtiter plates. To measure growth after several days of drug exposure, adherent cell layers are fixed, stained, and the plates washed in water to remove excess stain. After stained cells are air-dried and solubilized, absorbance is determined using spectrophotometers designed for reading of microtiter trays. This method is reproducible and offers the advantage that any adherent cell line can be utilized without the need for tedious cell-counting procedures.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6476363     DOI: 10.1016/0003-2697(84)90002-2

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  26 in total

1.  [Not Available].

Authors:  T Schulz; K Senkpiel; H Ohgke
Journal:  Mycotoxin Res       Date:  2001-06       Impact factor: 3.833

2.  [Not Available].

Authors:  Torsten Schulz; Klaus Senkpiel; Helge Ohgke
Journal:  Mycotoxin Res       Date:  2002-06       Impact factor: 3.833

3.  Bruceine B, a potent inhibitor of leukocyte-endothelial cell adhesion.

Authors:  N Utoguchi; T Nakata; H H Cheng; K Ikeda; H Makimoto; Y Mu; S Nakagawa; M Kobayashi; I Kitagawa; T Mayumi
Journal:  Inflammation       Date:  1997-04       Impact factor: 4.092

4.  Interleukin-1 beta upregulates tissue-type plasminogen activator in a keratinocyte cell line (HaCaT).

Authors:  J M Rox; J Reinartz; M D Kramer
Journal:  Arch Dermatol Res       Date:  1996-08       Impact factor: 3.017

5.  In vivo and in vitro anticancer activity of the structurally novel and highly potent antibiotic CI-940 and its hydroxy analog (PD 114,721).

Authors:  B J Roberts; K L Hamelehle; J S Sebolt; W R Leopold
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

6.  Rapid chemosensitivity testing of human lung tumor cells using the MTT assay.

Authors:  S P Cole
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

7.  Oxygen dependence of the cytotoxicity of the enediyne anti-tumour antibiotic esperamicin A1.

Authors:  R M Batchelder; W R Wilson; M P Hay; W A Denny
Journal:  Br J Cancer Suppl       Date:  1996-07

8.  Lectinophagocytosis of encapsulated Klebsiella pneumoniae mediated by surface lectins of guinea pig alveolar macrophages and human monocyte-derived macrophages.

Authors:  A Athamna; I Ofek; Y Keisari; S Markowitz; G G Dutton; N Sharon
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

9.  The PIT method: an automated in vitro technique for drug toxicity testing.

Authors:  R van Lambalgen; P Lelieveld
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

10.  In vitro assessment of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide, a DNA-intercalating antitumour drug with reduced sensitivity to multidrug resistance.

Authors:  G J Finlay; E Marshall; J H Matthews; K D Paull; B C Baguley
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.